Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team…
JUPITER, Fla., March 26, 2026 (GLOBE NEWSWIRE) — Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced it has appointed two leading healthcare investors, Peter Renehan, MD, and Lee Brown as Vice Presidents of Investments and Business De… [3072 chars]
Source: GlobeNewswire | Published: 2026-03-26T11:00:00Z
Credit: GlobeNewswire
